Skip to main content
Top
Published in: International Journal of Hematology 4/2013

01-10-2013 | Images in Hematology

Erdheim–Chester disease and Schnitzler syndrome: so near, and yet so far

Authors: Petr Szturz, Libor Hlavatý, Jiří Prášek, Dana Dvořáková

Published in: International Journal of Hematology | Issue 4/2013

Login to get access

Excerpt

A 56-year-old male presented with diabetes insipidus, non-infectious fever, night sweats, and pain in both lower legs and pelvis. Developing gradually over a period of 9 years, these symptoms were accompanied by increased acute phase markers (C-reactive protein = 63 mg/L, erythrocyte sedimentation rate = 52 mm/h and 72 mm/2 h, fibrinogen = 6.5 g/L). Technetium-99m pyrophosphate bone scintigraphy showed abnormal tracer uptake predominantly in the long bones of the lower extremities, with additional hot spots in the skull, right shoulder, left humerus, and both radial bones (Fig. 1). Positron emission tomography (PET) identified a similar pattern of 18F-fluorodeoxyglucose uptake correlating with osteosclerotic lesions on conventional radiography (X-ray) and computed tomography (CT). Subsequently, histological findings of CD68- and S100-positive, CD1a-negative foamy histiocytes from a bone biopsy were compatible with Erdheim–Chester disease. Moreover, the obtained tissue samples were positive for BRAF V600E mutation on CE-IVD validated BRAF 600/601 StripAssay (ViennaLab Diagnostics GmbH, Austria) (Fig. 2).
Literature
1.
go back to reference Simon A, Asli B, Braun-Falco M, De Koning H, Fermand JP, Grattan C, et al. Schnitzler’s syndrome: diagnosis, treatment, and follow-up. Allergy. 2013;68:562–8.PubMedCrossRef Simon A, Asli B, Braun-Falco M, De Koning H, Fermand JP, Grattan C, et al. Schnitzler’s syndrome: diagnosis, treatment, and follow-up. Allergy. 2013;68:562–8.PubMedCrossRef
2.
go back to reference Aubert O, Aouba A, Deshayes S, Georgin-Lavialle S, Rieu P, Hermine O. Favorable radiological outcome of skeletal Erdheim–Chester disease involvement with anakinra. Joint Bone Spine. 2013;80:206–7.PubMedCrossRef Aubert O, Aouba A, Deshayes S, Georgin-Lavialle S, Rieu P, Hermine O. Favorable radiological outcome of skeletal Erdheim–Chester disease involvement with anakinra. Joint Bone Spine. 2013;80:206–7.PubMedCrossRef
3.
go back to reference Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B, et al. High prevalence of BRAF V600E mutations in Erdheim–Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120:2700–3.PubMedCrossRef Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B, et al. High prevalence of BRAF V600E mutations in Erdheim–Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120:2700–3.PubMedCrossRef
Metadata
Title
Erdheim–Chester disease and Schnitzler syndrome: so near, and yet so far
Authors
Petr Szturz
Libor Hlavatý
Jiří Prášek
Dana Dvořáková
Publication date
01-10-2013
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2013
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-013-1437-2

Other articles of this Issue 4/2013

International Journal of Hematology 4/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine